TLR7 & TLR8 Knockout THP-1 Cell Line

The choice depends on whether you are studying ssRNA virus sensing, vaccine adjuvant mechanisms, or the redundancy and specialization between TLR7 and TLR8. The double Knockout line is appropriate for asking whether TLR7 and TLR8 are required jointly for these processes — single TLR7 or TLR8 knockouts often show mild phenotypes due to functional redundancy, which the double knockout eliminates. Overexpression is useful for testing receptor-specific ligand selectivity or for sufficiency studies. For TLR7/8 research, the EDITGENE Double Knockout in THP-1 is highly informative for vaccine adjuvant development (R848/resiquimod and related TLR7/8 agonists are clinical-stage adjuvants) and antiviral immunity studies — THP-1 is the standard human monocytic cell line for innate immune signaling research. Rescue with TLR7 alone or TLR8 alone enables direct dissection of receptor-specific contributions in a clean double-knockout background, which is the gold standard experimental design for distinguishing TLR7 and TLR8 functions.

Primary applications: • ssRNA virus sensing: type I IFN and proinflammatory cytokine induction (IFN-α, TNF-α, IL-6) following ssRNA virus challenge or synthetic ssRNA stimulation. • TLR7/8 agonist specificity: critical genetic control for testing imidazoquinoline-class agonists (R848/resiquimod, imiquimod, gardiquimod) and newer TLR7- or TLR8-selective agonists for on-target activity. • Vaccine adjuvant research: assessment of TLR7/8 agonist-based adjuvant mechanisms in a clean TLR7/8-null monocytic background. • Receptor-specific rescue studies: re-introduction of TLR7 alone or TLR8 alone enables direct dissection of receptor-specific contributions in a clean double-knockout background. EDITGENE recommends this model for researchers in antiviral immunity, vaccine adjuvant development, and TLR7/8 agonist pharmacology.

Yes. TLR7/8 rescue experiments are uniquely valuable in this double knockout background: • Single-receptor rescue: re-introduction of TLR7 alone or TLR8 alone in the double knockout background is the gold-standard experimental design for distinguishing receptor-specific functions, since the two receptors are functionally redundant for many ssRNA ligands. • Construct design: use codon-modified TLR7 or TLR8 sequences with C-terminal tags. Both are type I membrane proteins with endosomal localization — N-terminal signal peptides must be preserved. • Endosomal localization validation: confirm endosomal compartment localization by immunofluorescence (LAMP1, Rab9 co-staining) before functional assays. • Agonist selectivity studies: TLR7-selective agonists (gardiquimod) versus TLR8-selective agonists (VTX-2337/motolimod) and dual agonists (R848) can be directly compared in single-rescue lines. THP-1 is a suspension cell line — transduction is typically performed via spinoculation with lentivirus; consider PMA-induced differentiation context for functional readouts.